SABCS – Data on Exact Sciences’ Oncotype DX in Guiding Treatment Decisions
Returning guest and study author, Steve Shak, Chief Medical Officer at Exact Sciences discusses results presented at SABCS (San Antonio Breast Cancer Sy...
Returning guest and study author, Steve Shak, Chief Medical Officer at Exact Sciences discusses results presented at SABCS (San Antonio Breast Cancer Sy...
John Huemoeller, CEO of AXIM Biotechnologies, an international healthcare solutions company based in San Diego targeting oncological and COVID-19 resear...
Dave Marver, CEO of ONWARD, discusses the work they are doing with both non-invasive and implantable neuromodulation technologies to improve the quality...
Paul Brennan, President and CEO of NervGen Pharma Corp, developer of treatments related to nerve damage and neurodegenerative diseases, discusses the st...
Steven Engle, CEO of CohBar, Inc, a clinical stage biotechnology company discusses his article in "Grit Daily" (Jan 8, 2021) on NASA's breakthrough stud...
Mike, a clinical psychologist discusses the podcast he is hosting called "Going There". Learn more on Health Professional Radio.
Tania Gonzalez-Rivera, MD, BENLYSTA Global Medical Affairs Lead at GlaxoSmithKline (GSK) discusses the recent FDA approval of BENLYSTA (Belimumab) the f...
Ed Baker, FACOG, an OB/GYN and Senior Director, Medical Affairs, Cervical Cancer Solutions at Roche Molecular Diagnostics, discusses advanced biomarker ...
Louis Aronne, MD, FACP, Chief Medical Officer of Intellihealth and medical director of the Comprehensive Weight Control Center at Weill Cornell, discuss...
There has been a drastic drop in breast and colorectal cancer screenings. Hospitals that are overrun and overwhelmed have prolonged and, in many cases...